Baldrige Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Baldrige Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$14K	Hold	24	–	–	0.01%	243
2022 Q4	$13K	Hold	24	–	–	0.01%	240
2022 Q3	$12K	Hold	24	–	–	0.01%	241
2022 Q2	$13K	Hold	24	–	–	0.01%	244
2022 Q1	$14K	Buy	+24	New	+$13.8K	0.01%	254
2021 Q4	–	Sell	-23	Closed	-$13K	–	359
2021 Q3	$13K	Hold	23	–	–	0.01%	264
2021 Q2	$12K	Buy	+23	New	+$10.9K	0.01%	275

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baldrige Asset Management's TMO Position: Q1 2023 in Review

Baldrige Asset Management held its Thermo Fisher Scientific (TMO) position steady in Q1 2023 at 24 shares worth $14K. The position accounts for 0.01% of the portfolio, ranked #243.

Baldrige Asset Management first reported a position in TMO in Q2 2021 and has held it in 7 quarters since. 2,385 funds tracked by Wall St. Rank hold TMO as of Q1 2023.

Baldrige Asset Management held 24 shares of Thermo Fisher Scientific worth $14K as of Q1 2023.
Baldrige Asset Management left its Thermo Fisher Scientific share count unchanged in Q1 2023.
Thermo Fisher Scientific made up 0.01% of Baldrige Asset Management's portfolio in Q1 2023, its #243 holding.
Baldrige Asset Management first reported a position in Thermo Fisher Scientific in Q2 2021 and has held it in 7 quarters since.
2,385 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2023.

Based on Baldrige Asset Management's 13F filing for Q1 2023, filed 17 Apr 2023.